Liquidia Corporation To Present At The Jefferies Virtual Healthcare Conference
May 26, 2021 07:00 ET
|
Liquidia Corporation
MORRISVILLE, N.C., May 26, 2021 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that Mr. Damian deGoa, Chief Executive Officer of Liquidia, will provide an overview and...
Liquidia Announces Generic Treprostinil Injection Now Also Available for Subcutaneous Route of Administration
May 24, 2021 16:05 ET
|
Liquidia Corporation
MORRISVILLE, N.C., May 24, 2021 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (“Liquidia” or the “Company”) today announced that Sandoz Treprostinil Injection, a generic form of...
Liquidia Reports First Quarter 2021 Financial Results and Provides Corporate Update
May 13, 2021 07:00 ET
|
Liquidia Corporation
- Doubled the market opportunity for Treprostinil Injection by adding subcutaneous delivery- Resubmitted New Drug Application for LIQ861 (treprostinil) Inhalation Powder- Improved financial position...
Liquidia Resubmits New Drug Application for LIQ861 (treprostinil) Inhalation Powder for the Treatment of Pulmonary Arterial Hypertension
May 10, 2021 06:30 ET
|
Liquidia Corporation
MORRISVILLE, N.C., May 10, 2021 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that on May 7, 2021, it resubmitted its New Drug Application (NDA) for LIQ861 for the...
Liquidia Corporation to Report First Quarter 2021 Financial Results on May 13, 2021
May 06, 2021 07:00 ET
|
Liquidia Corporation
MORRISVILLE, N.C., May 06, 2021 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that it will report its first quarter 2021 financial results on Thursday, May 13, 2021. The...
Liquidia Corporation Announces $21.7 Million Private Placement
April 13, 2021 07:00 ET
|
Liquidia Corporation
RESEARCH TRIANGLE PARK, N.C., April 13, 2021 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that it has entered into a common stock purchase agreement with certain...
Liquidia Corporation To Present At The 20th Annual Needham Virtual Healthcare Conference
April 07, 2021 07:00 ET
|
Liquidia Technologies, Inc.
RESEARCH TRIANGLE PARK, N.C., April 07, 2021 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that Mr. Damian deGoa, Chief Executive Officer of Liquidia, will provide an...
Liquidia Announces Generic Treprostinil Injection Will Be Available for Subcutaneous Route of Administration
March 30, 2021 07:00 ET
|
Liquidia Technologies, Inc.
Addressable market for generic Treprostinil Injection more than doublesFDA cleared 510(k) for RG 3ml Medication Cartridge for use with CADD-MS® 3 pump RESEARCH TRIANGLE PARK, N.C., March 30, 2021...
Liquidia Corporation Reports Full-Year 2020 Financial Results and Provides Corporate Update
March 23, 2021 07:00 ET
|
Liquidia Technologies, Inc.
- Integrated RareGen (now known as Liquidia PAH) to establish commercial presence in PAH- Clarified path towards submitting response to CRL for LIQ861 in mid-2021- Reducing net annual spending more...
Liquidia Corporation to Host 2020 Financial Results Conference Call on March 23, 2021
March 09, 2021 07:30 ET
|
Liquidia Technologies, Inc.
RESEARCH TRIANGLE PARK, N.C., March 09, 2021 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced that 2020 financial results will be reported on Tuesday, March 23, 2021. The...